1. 66P Real-world data of first-line chemo-immunotherapy for patients with extensive stage SCLC: A multicentre experience from Switzerland and the UK. (December 2022) Authors: Moliner, L.; Zellweger, N.M.; Schmidt, S.M.; Waibel, C.; Froesch, P.R.; Häuptle, P.; Blum, V.; Holer, L.; Frueh, M.; Bhagani, S.; Gray, H-L.J.; Cox, S.; Khalid, T.; Scott, D.C.; Robinson, S.D.; Hennah, L.; Handforth, C.; Mauti, L.A.; Califano, R.; Rothschild, S.I. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tailored Anti-Cancer treatment in elderly cancer patients A registry study in Progress. (October 2022) Authors: Häuptle, P.; Mertz, K.; Voegeli, M.; Robert, R.; Burri, E.; Subotic, S.; Romanens, A.; Leuppi-Taegtmeyer, A.; Christian, R.; Wedeken, L.; Vetter, M. Journal: Journal of geriatric oncology Issue: Volume 13(2022)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗